Company Analysis

MeiraGTx Holdings plc (MGTX)

Nasdaq: MGTX · Biological Products, (No Diagnostic Substances) · New York, NY · filing with the SEC since 2018
Grade6.2
◀ Past 7.1● Present 5.9▶ Future 5.7
2 est.

Who runs MeiraGTx Holdings plc

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Forbes Alexandria
PRESIDENT & CEO. First filing Jun 2018, latest Aug 18, 2026, 18 filings in all.
Officers reporting now
6
of 16 people with a filing in the last fifteen months
Directors reporting now
10
22 people on the record since 2018
Officerssales are open-market, Oct 20, 2025 to Oct 20, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Giroux RichardCFO & COOJun 2018Oct 20, 20264 · $2.0M
Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGYJun 2018Oct 6, 20264 · $1.0M
Forbes AlexandriaPRESIDENT & CEOJun 2018Aug 18, 20263 · $1.9M
Zeldin Robert KCHIEF MEDICAL OFFICERAug 2020Jun 29, 2026none
Wollin Robert JGENERAL COUNSEL AND SECRETARYJun 2020Jun 29, 2026none
Fleck Penny ReneeCHIEF DEVELOPMENT OFFICERMay 2026May 14, 2026none
Directorssales are open-market, Oct 20, 2025 to Oct 20, 2026
NameRoleFirst filingLatest filingSales, 12 months
Sebulsky AlandirectorSep 2026Sep 24, 2026none
Edelman JosephdirectorJun 2018Jun 15, 2026none
Harris Keith R.directorJun 2018Jun 15, 2026none
Hukkelhoven EllendirectorJun 2018Jun 15, 2026none
Mendoza NeildirectorJun 2018Jun 15, 2026none
Perceptive Advisors LLCdirectorJun 2018Jun 15, 2026none
Perceptive Life Sciences Master Fund LtddirectorJun 2018Jun 15, 2026none
Seligman NicoledirectorMay 2019Jun 15, 2026none
Shenk Thomas EdirectorJun 2018Jun 15, 2026none
Yu DebradirectorApr 2022Jun 15, 2026none
Earlier names on the record9, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton MGTX · research, not advice